Figure 6.

LINC01535 promotes cervical cancer growth in vivo via repressing the miR‐214/EZH2 regulatory axis. A, LINC01535 and miR‐214 concurrently overexpressed, LINC01535 overexpressed and concurrently EZH2 silenced, and control HeLa cells were subcutaneously injected into nude mice. Tumour volumes were measured every 4 days. B, Subcutaneous tumour weights were measured at the 24th day after injection. C, Ki67 immunohistochemistry (IHC) staining of subcutaneous tumours derived from B. Scale bars, 50 μm. D, Cleaved caspase‐3 IHC staining of subcutaneous tumours derived from B. Scale bars, 50 μm. Results are shown as mean ± SD of n = 6 mice in each group. **P < 0.01, ***P < 0.001, ns, not significant, by Kruskal‐Wallis test followed by Dunnett's multiple comparison test